Detalhe da pesquisa
1.
Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan.
Circ J
; 80(4): 906-12, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26821583
2.
Impact of hemodialysis on clinical and angiographic outcomes in in-stent restenotic lesions following optical coherence tomography-guided drug-coated balloon treatment.
Cardiovasc Interv Ther
; 36(4): 429-435, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33048289
3.
Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
Am J Cardiol
; 101(6): 801-6, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18328844
4.
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
Circulation
; 112(25): 3876-83, 2005 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16344384
5.
Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry.
J Am Coll Cardiol
; 45(10): 1574-9, 2005 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-15893169
6.
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
J Am Coll Cardiol
; 46(2): 253-60, 2005 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-16022951
7.
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
J Am Coll Cardiol
; 45(6): 947-53, 2005 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15766834
8.
Sirolimus-eluting stents for the treatment of atherosclerotic ostial lesions.
J Invasive Cardiol
; 17(1): 10-2, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15640531
9.
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.
J Invasive Cardiol
; 17(8): 409-12, 2005 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16079445
10.
Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Am J Cardiol
; 94(7): 909-13, 2004 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15464675
11.
Complications of polymers on drug-eluting stents: looking toward polymer-free drug-eluting stents.
Intern Med
; 54(6): 549-50, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25786441
12.
Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials).
Am J Cardiol
; 102(8): 1009-16, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18929701
13.
Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.
Catheter Cardiovasc Interv
; 69(3): 380-6, 2007 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17195199
14.
Sirolimus-eluting versus paclitaxel-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: a combined RESEARCH and T-SEARCH long-term analysis.
J Am Coll Cardiol
; 47(3): 507-14, 2006 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-16458128
15.
Classification and current treatment options of in-stent restenosis. Present status and future perspectives.
Herz
; 29(2): 187-94, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15057440